TX-FLUENCE
Fluence by OSRAM (Fluence) has been selected by Wageningen University & Research (WUR) as the lighting provider for Serre Red, the university’s new, high-tech quarantine greenhouse. Serre Red will be used for critical research on plant diseases—caused by viruses, bacteria, fungi and parasitic nematodes—including quarantine pathogens, as well as research on genetically modified organisms.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200526005096/en/
Built by Bosman van Zaal, Serre Red is one of the most advanced quarantine research facilities constructed to date. It features 63 compartments, ranging from 15 to 52 square meters with individual climate control, air filtering and access locks. Extensive technical equipment has been installed in a corridor sunk below ground level to avoid excess shade. Other features of the fully electric greenhouse include insulated double glazing, external shading, heat/cold storage and autoclaving, which sterilizes all materials including water and waste before leaving the greenhouse.
Broad spectrum lighting: Choosing LED over HPS
To reduce the influence of artificial light on their experiments, WUR’s researchers required broad spectrum lighting. Unifarm, the university’s greenhouse and field research facility, ran a market consultation during November and December 2019, then selected four manufacturers from a tender in January 2020. Fluence was granted the order in April after the four potential solutions were examined by WUR’s scientific committee.
“Traditionally, our greenhouses are equipped with HPS lighting,” said Dolf Straathof, head of Unifarm. “As we want to eliminate any influences that artificial lighting could have on experiments, we looked for a solution that came closest to the spectrum that our scientific team specified as optimal.”
“Fluence was one of those consulted, and they proposed higher light levels than we initially specified, which concurred with recommendations from our researchers,” Straathof continued. “The PhysioSpec® solution that Fluence proposed also fit our spectral requirements. In the end, Fluence offered us the best possible solution and exceeded our requirements for uniformity, offering the highest uniformity for a mix of low and tall crops throughout all compartments.”
Optimizing light levels and uniformity
Each compartment will have individual lighting controls, linked to the Hoogendoorn climate control system.
“This is the first time WUR has chosen LED, and specifically broad spectrum LED, as their standard lighting solution for a research greenhouse at Unifarm,” said Theo Tekstra, Fluence’s technical director in Europe, the Middle East and Africa and lead for the project’s design and implementation. “LED solutions have the added advantage that they can be controlled without change in spectrum or loss of efficiency, offering constant light levels and optimal daily light integral. By using our compact VYPR 2x2 full spectrum LED fixtures with the new compact PSU drivers and VYPR reflectors, we minimize shading and optimize overall uniformity. We are extremely proud that our solution was selected as the best in the tender and that we were awarded the contract for this prestigious project.”
Critical research for the world’s growers
Fluence supports, sponsors and collaborates on horticultural research projects throughout the world, including its membership in the Wageningen Research Club of 100—part of the WUR Business Unit for Greenhouse Horticulture in Bleiswijk.
The spread of viral infections—such as the tomato brown rugose fruit virus (ToBRFV)—remains a top concern for growers throughout the world. The new Serre Red facility enables WUR to expand and intensify its research capabilities, maintaining its position as a world leader in research on horticultural crop pathogens.
“ToBRFV currently threatens tomato, bell pepper and chili pepper crops throughout the globe, causing most production greenhouses to close to visitors and creating increased costs for growers through extensive disinfection and other precautionary measures,” said Dr. Theoharis Ouzounis, horticultural scientist at Fluence. “There is no treatment other than prevention and pervasive damage has been reported globally. Research into prevention and treatment of viral diseases is extremely important to safeguard our food production.”
For more information about Fluence lighting solutions, visit www.fluence.science .
About Fluence by OSRAM
Fluence Bioengineering, Inc., a wholly-owned subsidiary of OSRAM , creates the most powerful and energy-efficient LED lighting solutions for commercial crop production and research applications. Fluence is a leading LED lighting supplier and is committed to enabling more efficient crop production with the world’s top vertical farms and greenhouse produce growers. Fluence global headquarters are based in Austin, Texas, with its EMEA headquarters in Rotterdam, The Netherlands. For more information about Fluence, visit www.fluence.science .
Link to high resolution pictures: www.fluence.science/press-links
View source version on businesswire.com: https://www.businesswire.com/news/home/20200526005096/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
DATROWAY® Type II Variation Application Validated in the EU as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who are Not Candidates for Immunotherapy18.12.2025 08:30:00 CET | Press release
Based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s DATROWAY is the first and only medicine to significantly improve overall survival versus chemotherapy in this patient population If approved, DATROWAY could become the standard of care in this setting The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for DATROWAY® (datopotamab deruxtecan) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. DATROWAY is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/Nasdaq: AZN). The validation confirms the completion of the application and commences the scientific review process by the EMA’s Committee for Medicinal Produc
Celltrion receives positive CHMP Opinion for SteQeyma™ (ustekinumab biosimilar) autoinjector18.12.2025 03:41:00 CET | Press release
SteQeyma™45mg and 90mg solution for injection via autoinjector (pre-filled pen) receives positive CHMP opinion, which will facilitate subcutaneous administration in patients with plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD)1The new autoinjector option increases convenience, enhances individual patient experience and expands administration options Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion of autoinjector of SteQeyma™, a biosimilar to Stelara® (ustekinumab), for the treatment of plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD). The positive CHMP opinion is for SteQeyma autoinjector in 45mg/0.5mL and 90mg/1mL, expanding the currently approved SteQeyma™ presentation, which includes 45mg/0.5mL, 90mg/1mL in a pre-filled syringe and 45mg/0.5mL in a vial for subcutaneous injection, as well as 130mg/26mL concentrate for solution f
Megaport Expands into India, Accelerating Global Growth with Extreme IX Acquisition18.12.2025 02:15:00 CET | Press release
Through the Extreme Exchange (IX) acquisition, Megaport gains seven Internet Exchanges and access to 40+ data centres across India’s fastest-growing digital hubs. Megaport Limited (ASX: MP1) (“Megaport”), the world’s leading Network as a Service (NaaS) provider, today announced the acquisition of Extreme IX,India’s leading Internet Exchange operator, from Extreme Labs, a Bulgaria-headquartered software and network engineering company that incubated the Extreme IX platform. The acquisition expands Megaport’s global platform into one of the world’s fastest-growing digital infrastructure markets and supports the Company’s strategy to deliver scalable, high-performance connectivity services across APAC. The acquisition establishes Megaport’s presence across seven Internet Exchanges in major Indian metros: Delhi, Kolkata, Hyderabad, Chennai, Bengaluru, Mumbai, and Pune, connecting 40+ data centres and more than 400 customers. It also accelerates Megaport’s planned market entry by nearly thr
IonQ and QuantumBasel Expand Long-Term Partnership in Next-Generation Quantum Systems17.12.2025 22:10:00 CET | Press release
Extension solidifies QuantumBasel as IonQ’s Innovation Center in Europe; adds IonQ Tempo and next-generation system to advance quantum commercialization IonQ (NYSE: IONQ), the world’s leading quantum company, today announced an expanded agreement with QuantumBasel, the quantum initiative of uptownBasel, Switzerland’s innovation campus. The extended contract grants QuantumBasel ownership of its existing IonQ Forte Enterprise system and secures ownership of a next-generation Tempo system. This new agreement brings the total deal value of the QuantumBasel and IonQ partnership to over $60 million and extends IonQ’s on-site presence in Switzerland four more years, continuing through 2029. QuantumBasel is IonQ’s official Innovation Center in Europe, serving as a hub for European industry, academia, and research institutions to explore practical quantum computing applications and access IonQ’s latest enterprise-grade systems. “Our extended partnership with QuantumBasel represents a cornerston
Suzano Starts Up New Production Line, Boosting Its Fluff Pulp Capacity by 400%17.12.2025 21:50:00 CET | Press release
A R$490 million investment expands the supply of raw material used in the production of absorbent items Suzano, the world’s largest pulp producer, has commenced operations this week at its new fluff pulp production line located in its Limeira unit in Brazil’s São Paulo state. This R$490 million investment increases Suzano’s total fluff pulp production capacity by more than 400%, from 100,000 to 440,000 tonnes per year. The project involved converting the existing pulp line at the Limeira unit into a flexible machine, capable of producing both Eucafluff® and market pulp. Eucafluff® is used in the production of absorbent and personal hygiene products, such as baby and adult diapers, sanitary pads and pet pads. Then market pulp is supplied for making products including toilet paper, printing and writing papers, and paper packaging. Launched in 2015, Eucafluff® is the world’s first fluff pulp made from eucalyptus, delivering unique advantages like enhanced softness and flexibility, which t
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
